RxDoctor Payments DataLook up a doctor →

FIRAZYR: payments to doctors

Payments that named FIRAZYR as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$17K
Providers
29
Transactions
35
Average per transaction
$498

The per-transaction average — $498 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 29 providers the average total is $601, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
Takeda Pharmaceuticals U.S.A., Inc.$16,81796.5%
Shire North American Group Inc$6163.5%
← All drugs & devices